Silicon Laboratories insider granted 8,669 RSUs

Silicon Laboratories senior vice president and general manager Robert J. Conrad received an equity grant in the form of 8,669 shares of common stock on February 15, 2026.

Rhea-AI Filing Summary

Silicon Laboratories senior vice president and general manager Robert J. Conrad received an equity grant in the form of 8,669 shares of common stock on February 15, 2026. These were awarded at a price of $0 per share as part of his compensation.

The award consists of restricted stock units that each convert into one share of common stock. One-third of the RSUs will vest on each of the first three anniversaries of the grant date under Silicon Laboratories’ 2009 Stock Incentive Plan. Following this grant, Conrad directly holds 34,049 shares of Silicon Laboratories common stock.

Insider Trade Summary

Grant/Award: 8,669 shares

Grant/Award 1 txn

Insider CONRAD ROBERT J

Role Sr VP and General Manager

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value	8,669	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.0001 par value — 34,049 shares (Direct)

Footnotes (1)

1. F1. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan (as amended from time to time).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Silicon Laboratories (SLAB) report for Robert J. Conrad?

Silicon Laboratories reported that Robert J. Conrad received a grant of 8,669 shares of common stock on February 15, 2026. The shares were awarded at $0 per share as part of an equity compensation grant of restricted stock units.

How many Silicon Laboratories (SLAB) shares does Robert J. Conrad own after this grant?

After the reported equity grant, Robert J. Conrad directly owns 34,049 shares of Silicon Laboratories common stock. This figure includes the newly granted 8,669 restricted stock units that will convert to shares as they vest over time.

What type of equity did Robert J. Conrad receive from Silicon Laboratories (SLAB)?

Robert J. Conrad received restricted stock units (RSUs) linked to Silicon Laboratories common stock. Each RSU entitles him to receive one share of common stock, subject to vesting conditions set under the company’s 2009 Stock Incentive Plan.

What is the vesting schedule for Robert J. Conrad’s Silicon Laboratories (SLAB) RSUs?

The 8,669 RSUs granted to Robert J. Conrad vest in three equal installments. One-third of the units will vest on each of the first three anniversaries of the February 15, 2026 grant date, assuming plan conditions are met.

At what price were Robert J. Conrad’s Silicon Laboratories (SLAB) RSUs granted?

The RSUs reported for Robert J. Conrad were granted at a stated price of $0 per share. This reflects that the award is a compensation grant of restricted stock units rather than an open-market purchase of Silicon Laboratories shares.

Under which plan were Robert J. Conrad’s Silicon Laboratories (SLAB) RSUs issued?

Robert J. Conrad’s restricted stock units were granted under Silicon Laboratories’ 2009 Stock Incentive Plan, as amended from time to time. The plan governs vesting, settlement into common shares, and other terms associated with his equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 01:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CONRAD ROBERT J

(Last) (First) (Middle)

400 W CESAR CHAVEZ

(Street)

AUSTIN TX 78701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SILICON LABORATORIES INC. [ SLAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr VP and General Manager

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	02/15/2026		A		8,669(1)	A	$0	34,049	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan (as amended from time to time).

Remarks:

	Saie-Yau Hui for Robert J Conrad	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.